1 |
BENGTSSON A, ANDERSSON R, ANSARI D. The actual 5-year survivors of pancreatic ductal adenocarcinoma based on real-world data[J]. Sci Rep, 2020, 10(1): 16425.
|
2 |
GUO X F, SONG Y N, XU P J, et al. Selective extended dissection for pancreaticoduodenectomy is associated with better survival in pancreatic cancer patients: retrospective cohort study[J]. Int J Surg, 2023, 109(7): 1852-1862.
|
3 |
GOTTUMUKKALA S, SALAMEKH S, SANFORD N N. Current state and future directions of radiation therapy for pancreas adenocarcinoma[J]. Surg Oncol Clin N Am, 2023, 32(3): 399-414.
|
4 |
SMAGLO B G. Role for neoadjuvant systemic therapy for potentially resectable pancreatic cancer[J]. Cancers, 2023, 15(8): 2377.
|
5 |
REGAN S L, WILLIAMS M T, VORHEES C V. Latrophilin-3 disruption: effects on brain and behavior[J]. Neurosci Biobehav Rev, 2021, 127: 619-629.
|
6 |
HAMANN J, AUST G, ARAÇ D, et al. International Union of Basic and Clinical Pharmacology. ⅩCⅣ. Adhesion G protein-coupled receptors[J]. Pharmacol Rev, 2015, 67(2): 338-367.
|
7 |
LIEBSCHER I, CEVHEROĞLU O, HSIAO C C, et al. A guide to adhesion GPCR research[J]. FEBS J, 2022, 289(24): 7610-7630.
|
8 |
SASAKI S I, ZHANG D, IWABUCHI S, et al. Crucial contribution of GPR56/ADGRG1, expressed by breast cancer cells, to bone metastasis formation[J]. Cancer Sci, 2021, 112(12): 4883-4893.
|
9 |
WU G X, ZHAI D F, XIE J M, et al. N6-methyladenosine (m6 A) RNA modification of G protein-coupled receptor 133 increases proliferation of lung adenocarcinoma[J]. FEBS Open Bio, 2022, 12(3): 571-581.
|
10 |
MOSCA S, CARDINALI G, FLORI E, et al. The PI3K pathway induced by αMSH exerts a negative feedback on melanogenesis and contributes to the release of pigment[J]. Pigment Cell Melanoma Res, 2021, 34(1): 72-88.
|
11 |
ABBAS A, JUN P, YUAN J Y, et al. Downregulation of GPR160 inhibits the progression of glioma through suppressing epithelial to mesenchymal transition (EMT) biomarkers[J]. Basic Clin Pharmacol Toxicol, 2022, 131(4): 241-250.
|
12 |
LUM A M, WANG B B, BECK-ENGESER G B, et al. Orphan receptor GPR110, an oncogene overexpressed in lung and prostate cancer[J]. BMC Cancer, 2010, 10: 40.
|
13 |
MA B T, ZHU J J, TAN J, et al. Gpr110 deficiency decelerates carcinogen-induced hepatocarcinogenesis via activation of the IL-6/STAT3 pathway[J]. Am J Cancer Res, 2017, 7(3): 433-447.
|
14 |
BHAT R R, YADAV P, SAHAY D, et al. GPCRs profiling and identification of GPR110 as a potential new target in HER2+ breast cancer[J]. Breast Cancer Res Treat, 2018, 170(2): 279-292.
|
15 |
ZHU X L, HUANG G Q, JIN P F. Clinicopathological and prognostic significance of aberrant G protein-couple receptor 110 (GPR110) expression in gastric cancer[J]. Pathol Res Pract, 2019, 215(3): 539-545.
|
16 |
DE GROOT D M, VOGEL G, DULOS J, et al. Therapeutic antibody targeting of CD97 in experimental arthritis: the role of antigen expression, shedding, and internalization on the pharmacokinetics of anti-CD97 monoclonal antibody 1B2[J]. J Immunol, 2009, 183(6): 4127-4134.
|
17 |
GIERA S, LUO R, YING Y Q, et al. Microglial transglutaminase-2 drives myelination and myelin repair via GPR56/ADGRG1 in oligodendrocyte precursor cells[J]. eLife, 2018, 7: e33385.
|
18 |
NILE A H, HANNOUSH R N. Fatty acid recognition in the Frizzled receptor family[J]. J Biol Chem, 2019, 294(2): 726-736.
|
19 |
LIU Z Q, ZHANG G R, ZHAO C L, et al. Clinical significance of G protein-coupled receptor 110 (GPR110) as a novel prognostic biomarker in osteosarcoma[J]. Med Sci Monit, 2018, 24: 5216-5224.
|
20 |
ABDULKAREEM N M, BHAT R, QIN L F, et al. A novel role of ADGRF1 (GPR110) in promoting cellular quiescence and chemoresistance in human epidermal growth factor receptor 2-positive breast cancer[J]. FASEB J, 2021, 35(7): e21719.
|